TS422206795	drug 110 205	inhibitor of vascular endothelial growth factor receptor 2 and epidermal growth factor receptor
TS522206795	drug 183 196	growth factor
TS1322206795	mealTime 963 966	fed
TS922206795	mealTime 971 988	fasted conditions
TS2322206795	drug 1420 1431	metabolites
TS622206795	drug 2573 2583	vandetanib
TS1222206795	food 2403 2407	food
TS2222206795	food 2464 2468	food
TS2122206795	mealTime 2496 2503	fasting
TS2022206795	drug 2659 2670	metabolites
TS222206795	drug 2712 2723	metabolites
TS822206795	mealTime 3240 3243	fed
TS122206795	mealTime 3248 3265	fasted conditions
TS722206795	sideeffect 3561 3570	Hematuria
TS1822206795	food 4249 4253	food
TS2422206795	drug 4382 4417	N-desmethyl and N-oxide metabolites
T1	drug 20 30	vandetanib
T2	drug 76 86	Vandetanib
T3	modeadm 93 99	orally
T4	modeadm 644 648	oral
T5	drug 658 668	vandetanib
T6	drug 829 839	vandetanib
T7	dosage 842 853	300-1200 mg
T8	drug 939 949	vandetanib
T9	drug 1044 1054	vandetanib
T10	dosage 950 956	300 mg
T11	dosage 1055 1061	800 mg
T12	drug 1310 1320	vandetanib
T13	sideeffect 1513 1527	adverse events
T14	drug 2053 2063	vandetanib
T15	dosage 2064 2070	800 mg
T16	drug 2255 2265	Vandetanib
T17	modeadm 2314 2318	oral
T18	drug 2683 2693	vandetanib
T19	drug 2726 2747	N-desmethylvandetanib
T20	drug 2752 2770	vandetanib N-oxide
T21	sideeffect 3069 3083	Adverse events
T22	drug 3143 3153	vandetanib
T23	dosage 3162 3168	300 mg
T24	drug 3223 3233	vandetanib
T25	sideeffect 3347 3361	adverse events
T26	sideeffect 3454 3505	increases in systolic and diastolic blood pressures
T27	sideeffect 3519 3528;3546 3558	increases QTc interval
T28	drug 3600 3610	vandetanib
T29	dosage 3611 3617	300 mg
T30	drug 3735 3745	vandetanib
T31	drug 3951 3961	vandetanib
T32	drug 4060 4070	Vandetanib
T33	modeadm 4161 4165	oral
T34	drug 4367 4377	vandetanib
T35	drug 4464 4474	Vandetanib
